Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 6 papers. Top paper: “Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02”.
John G. Kuhn, Kathleen R. Lamborn, Lauren E. Abrey, Lisa M. DeAngelis, Frank S. Lieberman +14 more
Matthew S. Brown, Jerrold L. Boxerman, Elizabeth R. Gerstner, Timothy J. Kaufmann, Patricia E. Cole +10 more
Jing Wu, Ying Yuan, Terri S. Armstrong, Elizabeth Vera, Jimin Wu +18 more
Shaofang Wu, Yingli Lv, Juechen Yang, W.K. Alfred Yung, Jonathan Gelfond +5 more
Li Jiang, Erik Samuelsson, Sergio Marco Salas, Alexander Beck, Olivia A. Hack +41 more
Anjan Misra, Li Zhang, I. Smirnov, Howard Colman, Chandi Griffin +8 more